Estonian University of Life Sciences, Tartu, Estonia
Olavi Reinsalu received his diplomas for his bachelor’s and master’s degree in the curriculum of gene technology at the University of Tartu in 2012 and 2015, respectively. For the research of his master’s thesis he studied virus-like particles carrying melanoma antigens. After graduation he worked for three years as a researcher in University of Tartu and Competence Center of Health Technologies developing a bovine fluorescence in situ hybridization technique as part of a R&D project for agricultural enterprises. Starting from fall 2018 he became a doctoral student in University of Tartu studying in the curriculum of technology and engineering specializing in biomedical technology and later defended his thesis in 2022. His PhD study is continuation of his research from master’s and is also about extracellular vesicles and virus-like particles carrying melanoma antigens. He received his PhD in 2022. Now he is working as a post-doc studying synthetic vesicles (also known as liposomes) as drug delivery vehicles.